Association Between Testosterone with Type 2 Diabetes in Adult Males, a Meta-Analysis and Trial Sequential Analysis

Jianzhong Zhang,Xiao Li,Zhonglin Cai,Hongjun Li,Bin Yang
DOI: https://doi.org/10.1080/13685538.2018.1557139
2019-01-01
Abstract:We performed this meta-analysis to assess serum testosterone changes in adult males with Type 2 diabetes (T2DM).PubMed, Embase, Web of Science, and Cochrane Library were searched to identify qualified studies. Pooled weighted mean differences (WMDs) with 95% confidence intervals (CIs) were utilized to test the changes of total testosterone (TT), free testosterone (FT) and sex hormone-binding globulin (SHBG) in patients with T2DM. Besides, trial sequential analysis was used to verify the pooled results.A total of 56 studies were enrolled in our meta-analysis. Meta-analyses of the cross-sectional studies showed that patients with T2DM has significant decreases in TT (WMD: -2.98, 95%CI: -3.48 to -2.47), FT (WMD: -32.82, 95%CI: -39.70 to -25.95) and SHBG (WMD: -2.47, 95%CI: -3.93 to -1.02). In terms of the prospective studies, our results showed decreases in TT (WMD: -2.35, 95%CI: -3.24 to -1.46), FT (WMD: -25.96, 95%CI: -83.98 to 32.05), and SHBG (WMD: -10.06, 95%CI: -13.29 to -6.84) in patients with T2DM. By trial sequential analyses, the findings in current meta-analysis were based on reliable evidence.Our results indicate that patients with T2DM have lower serum TT, FT, and SHBG levels.
What problem does this paper attempt to address?